AVENIO Tumor Tissue Expanded Kit – Expanded Tumor Profiling

Material Number: Select a variation

Next-generation sequencing (NGS) tumor profiling assay for identifying genomic aberrations derived from solid tumors, containing 77 genes.

The AVENIO Tumor Tissue Expanded Kit is an NGS assay for expanded profiling of solid tumors in formalin-fixed paraffin-embedded (FFPE) tissue samples.  This assay contains 77 genes in the U.S. National Comprehensive Cancer Network (NCCN) 1 and other guidelines, plus 60 emerging biomarkers investigated in clinical trials.


  • Panel size: 192 kb
  • Sample size: 2×10 µm FFPT curls/sections
  • DNA input: 20 ng of amplifiable DNA
  • Reactions per kit: 24
  • Turn-around time: 5 days from extraction to results
The present kits include the following subkits:

* Based on the plate you choose.

For more information or further assistance, please reach out to our local representative through the contact form.

: Table demonstrating the performance of AVENIO Tumor Tissue Analysis kits

AVENIO Tumor Tissue Targeted Kit is a part of the AVENIO family of NGS oncology assays that include three tumor tissue and three corresponding ctDNA assays. By using the wider family of AVENIO assays, labs can obtain detailed molecular findings across all four mutation classes from tissue or plasma samples.







  1. National Comprehensive Cancer Network. October 15, 2016
  1. Data on file.